AdAlta Ltd
Cameron Jones, Managing Director at Bio101 since June 2016, leads a financial services firm focused on accounting, tax, and company secretarial services within the life science sector. In addition to this role, Cameron serves as Director at BioAutism, contributing to autism research funding in Australia, and is also a Director at Cystic Fibrosis Community Care, a charity supporting individuals with Cystic Fibrosis. Cameron holds the position of Company Secretary at AdAlta Ltd and previously worked as an Associate Advisor and Analyst at Pitcher Partners. Academic qualifications include a Graduate Diploma CA from Chartered Accountants Australia and New Zealand, a Diploma of Financial Planning from Kaplan Professional, and a Bachelor's degree in Accounting and Finance from Monash University. Cameron is also a Registered Tax Agent with the Tax Practitioners Board.
This person is not in any teams
AdAlta Ltd
AdAlta (ASX:1AD) is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease. AdAlta is utilising the power of its i-body technology platform to develop a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.